Canada Generic Drug Market PDF | Growth | Trends | Forecast to 2021-2026

1. Canada Generic Drug Market Research Report and Forecast 2021-2026 Author: Elena Anderson, Marketing Manager | Copyright © IMARC Service Pvt Ltd. All Rights Reserved IMARC Group © 2019 IMARC All Rights Reserved

2. Report DescriptionAbout IMARC Group The International Market Analysis Research and Consulting Group is a leading adviser on management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value challenges, and transform their businesses. opportunities, address their most critical IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, chemicals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise. IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and markets with close cooperation at all levels of the client organization. This ensures that our clients achieve unmatchable competitive advantage, build more proficient organizations, and secure lasting results.

3. Report Description and Highlights Report Description Canada Generic Drug Market Outlook 2026: According to the latest report by IMARC Group, titled “Canada Generic Drug Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026”, The Canada generic drug market reached a value of US$ 6.4 Billion in 2020. Generic drugs refer to medications that have the same active ingredients and therapeutic effect as that of a branded drug. These drugs can be oral, intravenous, intramuscular, topical or inhalant. They do not require extensive marketing due to the established safety and efficacy profile of their branded counterparts. Generic drugs can only be introduced once the patent protection of the associated brand-name drug has expired. In recent years, there has been a rise in healthcare spending in Canada on account of the growing geriatric population, which in turn has resulted in high demand for pharmaceutical products like generic drugs. Also, an increase in government policies supporting research and development (R&D) have further strengthened Canada’s expertise in niche areas such as biologics and oncology. Request for a free sample: https://www.imarcgroup.com/canada-generic-drug-market/requestsample

4. Report Description and Highlights Report Description Canada Generic Drug Market Trends: A large population of Canada has been diagnosed with numerous lifestyle conditions such as cardiovascular diseases (CVDs), cancer, chronic respiratory diseases (CRDs) and diabetes. This, along with the aging population, has created a heightened demand for cost-effective drugs in the country. As generic drugs are economical counterparts of branded drugs, they play a crucial role in lowering the overall treatment costs of these diseases. Owing to this, the Government of Canada is introducing supportive policies, which are favorable for the generic medicines industry. For instance, the Government has introduced public drug programs, such as the Ontario Drug Benefit (ODB) Program and Trillium Drug Program, as an initiative to provide universal healthcare in the country. Although these programs utilize both brand-name and generic drugs, they encourage physicians and patients to opt for generic medicines wherever available, so as to lower the overall drug expenditure. Moreover, several leading companies are engaged in research and development (R&D) activities to create complex and differentiated products. This is done either through acquisitions or by building their capabilities. Looking forward, IMARC Group expects the market to reach a value of US$ 7.0 Billion by 2026.

5. Report Description and Highlights Report Description Competitive Landscape With Key players: • Teva Pharmaceutical Industries Limited • Apotex Inc • Sandoz Inc • Sun Pharma Industries Ltd • Pharmascience Inc • Mylan N.V View Report TOC, Figures and Tables: https://www.imarcgroup.com/canada-generic-drug-market

6. We are the trusted business partners to the world's leading corporates, governments, and institutions Partial List of Clients A partial List of our Clients

7. We are the trusted business partners to the world's leading corporates, governments, and institutions Partial List of Clients A partial List of our Clients

8. Report Description and Highlights Report Description © 2019 IMARC All Rights Reserved This Publication and all it’s contents unless otherwise mentioned are copyrighted in the name of International Market Analysis Research and Consulting (IMARC). No part of this publication may be reproduced, repackaged, redistributed or resold in whole or in any part. The publication may also not be used in any form or by and means graphic electronic or mechanical, including photocopying, recording, taping or by information storage or retrieval, or by any other form, without the express consent of International Market Analysis Research and Consulting (IMARC). Disclaimer: All contents and data of this publication, including forecasts, data analysis and opinion have been based on information and sources believed to be accurate and reliable at the time of publishing. International Market Analysis Research and Consulting makes no representation of warranty of any kind as to the accuracy or completeness of any Information provided. IMARC accepts no liability whatsoever for any loss or damage resulting from opinion, errors or inaccuracies if any found this publication. IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of International Market Analysis Research and Consulting. All other trademarks used in this publication are registered trademarks of their respective companies.

9. Contact Us FOR MORE DETAILS Visit us at : https://www.imarcgroup.com Stay With Us: TELEPHONE: +1-631-791-1145 E-MAIL: sales@imarcgroup.com